Medpace (MEDP) director Brian Carley receives 1,110-share stock option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Medpace Holdings, Inc. director Brian T. Carley reported an equity compensation award and updated holdings. He received a grant of stock options covering 1,110 shares of common stock with an exercise price of $415.27 per share, expiring on May 15, 2033.
The option vests on the earlier of the day immediately before the first Medpace annual meeting after the grant date or the first anniversary of the grant, subject to his continued service on the board. Following the reported transactions, Carley directly holds 32,789 shares of Medpace common stock and 1,110 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Carley Brian T
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,110 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,110 shares (Direct, null);
Common Stock — 32,789 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Stock options granted: 1,110 options
Exercise price: $415.27 per share
Option expiration: May 15, 2033
+2 more
5 metrics
Stock options granted
1,110 options
Grant of Stock Option (Right to Buy) on common stock
Exercise price
$415.27 per share
Exercise price of granted stock options
Option expiration
May 15, 2033
Expiration date of stock option award
Common shares held
32,789 shares
Direct Medpace common stock holdings after transactions
Options held after grant
1,110 options
Total options reported following the award
Key Terms
Stock Option (Right to Buy), exercise price, vesting, board of directors
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "415.2700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option vests on the earlier of (i) the day immediately preceding..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
board of directors financial
"subject to continued service on the board of directors of the Issuer"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
What insider transaction did Medpace (MEDP) director Brian T. Carley report?
Brian T. Carley reported receiving a stock option grant for 1,110 shares of Medpace common stock. This is an equity compensation award, not an open-market purchase or sale, and reflects part of his compensation as a director.
What is the exercise price and term of Brian Carley’s new Medpace (MEDP) stock options?
The granted stock options have an exercise price of $415.27 per share and expire on May 15, 2033. This means Carley can choose to buy Medpace common shares at that price any time before the expiration date, once vested.
How and when do Brian Carley’s Medpace (MEDP) stock options vest?
The option vests on the earlier of the day immediately before the first annual meeting after the grant date or the first anniversary of the grant, provided Carley continues serving on Medpace’s board of directors through the vesting date.